These findings underscore the therapeutic relevance of targeting host autophagy, and in particular autophagy mechanisms mediated by the host BCL2-Interacting protein 3 (BNIP3), to intervene in infections with emerging SARS-CoV-2 VOCs. This evidence concerns the gene BNIP3 and infection.